Bourgeon Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-33,000
| Closed | -$190K | – | 101 |
|
|
2017
Q3 | $190K | Sell |
33,000
-6,000
| -15% | -$34.5K | 0.11% | 79 |
|
|
2017
Q2 | $124K | Buy |
39,000
+25,500
| +189% | +$81.1K | 0.08% | 75 |
|
|
2017
Q1 | $46K | Sell |
13,500
-30,219
| -69% | -$103K | 0.03% | 87 |
|
|
2016
Q4 | $126K | Buy |
43,719
+27,719
| +173% | +$79.9K | 0.08% | 87 |
|
|
2016
Q3 | $94K | Sell |
16,000
-4,000
| -20% | -$23.5K | 0.06% | 88 |
|
|
2016
Q2 | $60K | Buy |
+20,000
| New | +$60K | 0.04% | 89 |
|
|
2015
Q1 | – | Sell |
-25,000
| Closed | -$412K | – | 112 |
|
|
2014
Q4 | $412K | Buy |
+25,000
| New | +$412K | 0.25% | 76 |
|